MDxHealth (MDXH) Shares Outstanding (Weighted Average) (2020 - 2026)

MDxHealth has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $11000.0 for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $11000.0, down 99.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $11000.0 (down 99.99% YoY), and the FY2025 annual result was $42000.0, down 99.98% from the prior year.
• Shares Outstanding (Weighted Average) came in at $11000.0 for Q1 2026 at MDxHealth, down from $219.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $214.7 billion in Q2 2025 to a low of $10000.0 in Q3 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $173.1 million (2023), against an average of $13.5 billion.
• Across the five-year window, Shares Outstanding (Weighted Average) jumped 123322.51% in 2025 and slumped 99.99% in 2026, its largest moves.
• MDxHealth's Shares Outstanding (Weighted Average) stood at $16.3 million in 2022, then surged by 967.84% to $173.9 million in 2023, then gained by 23.42% to $214.7 million in 2024, then increased by 2.11% to $219.2 million in 2025, then slumped by 99.99% to $11000.0 in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $11000.0 (Q1 2026), $219.2 million (Q4 2025), and $60000.0 (Q3 2025), per Business Quant data.